Cargando…

Is there a role for inhaled ciclesonide in the treatment of COVID-19?

Detalles Bibliográficos
Autor principal:	Salvi, Sundeep Santosh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066939/ https://www.ncbi.nlm.nih.gov/pubmed/33402630 http://dx.doi.org/10.4103/lungindia.lungindia_473_20

Ejemplares similares

The efficacy and safety of inhaled corticosteroids: are we ignoring the potential advantages of ciclesonide?
por: van der Molen, Thys, et al.
Publicado: (2014)

Inhaled ciclesonide for outpatients with COVID-19: A meta-analysis
por: Hsu, Chi-Kuei, et al.
Publicado: (2022)

A randomized, double-blind study comparing the efficacy and safety of a combination of formoterol and ciclesonide with ciclesonide alone in asthma subjects with moderate-to-severe airflow limitation
por: Salvi, Sundeep S, et al.
Publicado: (2016)

Ciclesonide: a safe and effective inhaled corticosteroid for the treatment of asthma
por: Schaffner, Timothy J, et al.
Publicado: (2009)

Therapeutic potential of ciclesonide inhalation for COVID-19 pneumonia: Report of three cases
por: Iwabuchi, Keisuke, et al.
Publicado: (2020)

From inhaler to lung: clinical implications of the formulations of ciclesonide and other inhaled corticosteroids
por: Nave, Ruediger, et al.
Publicado: (2013)

Clinical benefits of inhaled ciclesonide for hospitalized patients with COVID-19 infection: a retrospective study
por: Kuo, Kuan-Chih, et al.
Publicado: (2022)

Ciclesonide Inhaler Treatment for Mild-to-Moderate COVID-19: A Randomized, Open-Label, Phase 2 Trial
por: Song, Joon-Young, et al.
Publicado: (2021)

Ciclesonide for the treatment of asthma
por: Dahl, Ronald
Publicado: (2006)

Inhaled and intranasal ciclesonide for the treatment of covid-19 in adult outpatients: CONTAIN phase II randomised controlled trial
por: Ezer, Nicole, et al.
Publicado: (2021)

Inhaled ciclesonide versus inhaled budesonide or inhaled beclomethasone or inhaled fluticasone for chronic asthma in adults: a systematic review
por: Dyer, Matthew J, et al.
Publicado: (2006)

Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE)
por: Duvignaud, Alexandre, et al.
Publicado: (2022)

Inhaled ciclesonide in adults hospitalised with COVID-19: a randomised controlled open-label trial (HALT COVID-19)
por: Brodin, Daniel, et al.
Publicado: (2023)

A randomized clinical trial on inhaled ciclesonide for managing acute asthma in the emergency room
por: Martins, Demétrius Tierno, et al.
Publicado: (2022)

Profile of ciclesonide for the maintenance treatment of asthma
por: Singas, Effie, et al.
Publicado: (2011)

Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled Corticosteroids
por: Postma, Dirkje S., et al.
Publicado: (2017)

Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia
por: Mori, Nobuaki, et al.
Publicado: (2021)

Efficacy of ciclesonide in the treatment of patients with asthma exacerbation
por: Zietkowski, Ziemowit, et al.
Publicado: (2019)

Similar Results in Children with Asthma for Steady State Pharmacokinetic Parameters of Ciclesonide Inhaled with or without Spacer
por: Boss, H., et al.
Publicado: (2010)

The peripheral lymphocyte count as a predictor of severe COVID-19 and the effect of treatment with ciclesonide
por: Yamasaki, Yukitaka, et al.
Publicado: (2020)

New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide
por: Braido, F, et al.
Publicado: (2008)

Intranasal ciclesonide for allergic rhinitis
por: Williams, Ben, et al.
Publicado: (2008)

Inhaled ciclesonide is efficacious and well tolerated in the treatment of severe equine asthma in a large prospective European clinical trial
por: Pirie, Robert Scott, et al.
Publicado: (2021)

AYUSH for COVID-19 management
por: Tillu, Girish, et al.
Publicado: (2020)

Uptake and metabolism of ciclesonide and retention of desisobutyryl-ciclesonide for up to 24 hours in rabbit nasal mucosa
por: Sato, Hideyuki, et al.
Publicado: (2007)

Efficacy and Safety of Inhaled Ciclesonide in Treating Patients With Asymptomatic or Mild COVID-19 in the RACCO Trial: Protocol for a Multicenter, Open-label, Randomized Controlled Trial
por: Terada-Hirashima, Junko, et al.
Publicado: (2020)

Closing gaps in asthma care in India – World Asthma Day 2022
por: Mortimer, Kevin, et al.
Publicado: (2022)

Enhanced alveo pulmonary deposition of nebulized ciclesonide for attenuating airways inflammations: a strategy to overcome metered dose inhaler drawbacks
por: El-Laithy, Hanan M., et al.
Publicado: (2021)

112 Comparison of the Use Ciclesonide Versus Fluticasone for the Treatment of Asthma in Children
por: Oropeza, Said Arablin, et al.
Publicado: (2012)

Comparison of Intranasal Ciclesonide, Oral Levocetirizine, and Combination Treatment for Allergic Rhinitis
por: Kim, Chang-Hoon, et al.
Publicado: (2015)

A Case of Coronavirus Disease 2019 Treated With Ciclesonide
por: Nakajima, Kento, et al.
Publicado: (2020)

Use of Thiols in the Treatment of COVID-19: Current Evidence
por: Cazzola, Mario, et al.
Publicado: (2021)

Ciclesonide in persistent asthma: the evidence of its therapeutic value
por: Kenreigh, Charlotte A., et al.
Publicado: (2006)

The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells
por: Matsuyama, Shutoku, et al.
Publicado: (2020)

Frequent occurrence of mutations in nsp3 and nsp4 of SARS-CoV-2, presumably caused by the inhaled asthma drug ciclesonide
por: Doi, Akihiro, et al.
Publicado: (2022)

COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial Effect of Inhaled Corticosteroids?
por: Maes, Tania, et al.
Publicado: (2020)

A randomized, double-blind study comparing the efficacy and safety of a combination of formoterol and ciclesonide with ciclesonide alone in asthma subjects with moderate-to-severe airflow limitation
por: Barthwal, Madhu Sudan, et al.
Publicado: (2017)

COVID‐19 pneumonia suspected to be co‐infection with Mycoplasma pneumoniae and improved by early administration of favipiravir and ciclesonide
por: Ito, Keima, et al.
Publicado: (2021)

Metabolism of ciclesonide in the upper and lower airways: review of available data
por: Nave, Ruediger, et al.
Publicado: (2008)

Molecular pharmacology of ciclesonide against SARS-CoV-2
por: Kimura, Hirokazu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bf9dn854h5dccf766ice1v3ehs